CRBP in the 13F filings

Corbus Pharmaceuticals HLDGS · CUSIP 21833P301

New listing in Q2 2024· first held by a tracked manager this quarter, so its new positions are allocations rather than a turn towards it

Quarter end
30 Jun 2024
the date the book describes
Filed
14 Aug 2024
latest of these filings; the earliest 13 Aug 2024
Managers listing it
3
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q1 2024 and Q2 2024; 1 listed it in both
Shares listed
505,830
combined, among listed positions
Reported value
$23m
combined, at the quarter end

Among the 94 comparable managers: 3 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing CRBP in Q2 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

3 of 3 holders

ActionFiling
Woodline Partners LP249,259$11m0.11%Added+208,27814 Aug 2024 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC140,300$6.3munder 0.1%Addedn.a.14 Aug 2024 (the filing on sec.gov)
ExodusPoint Capital Management LP116,271$5.3munder 0.1%Newnew13 Aug 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2024 to Q2 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
3 in Q1 2024 to 3 in Q2 2024

Tracked managers listing it, at least.

0123Q1 2024Q2 2024
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CRBP by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20243$31m30
Q2 20243$23m30

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CRBP and LLY →CRBP and JNJ →CRBP and VRTX →Choose a stock to compare with CRBP →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CRBP, latest filings →Back to the 13F Explorer →